Advanced search
Publication Cover
Nanomedicine Volume 8, 2013 - Issue 7
Submit an article Journal homepage
542
Views
0
CrossRef citations to date
0
Altmetric
Review

Nanoengineering Approaches to The Design of Artificial Antigen-Presenting Cells

Joel C Sunshine1 Department of Biomedical Engineering & the Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD21231, USAView further author information
&
Jordan J Green1 Department of Biomedical Engineering & the Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD21231, USA;2 Wilmer Eye Institute & the Institute for Nanobiotechnology, Johns Hopkins University School of Medicine, Baltimore, MD21231, USACorrespondence[email protected]
View further author information
Pages 1173-1189 | Published online: 25 Jun 2013

References

  • Kawakami Y , EliyahuS, DelgadoCHet al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl Acad. Sci. USA 91(9), 3515–3519 (1994).
  • van der Bruggen P , TraversariC, ChomezPet al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254(5038), 1643–1647 (1991).
  • Novellino L , CastelliC, ParmianiG. A listing of human tumor antigens recognized by T cells: March 2004 update. Cancer Immunol. Immunother.54(3), 187–207 (2005).
  • Kantoff PW , HiganoCS, ShoreNDet al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N. Engl. J. Med. 363(5), 411–422 (2010).
  • Oelke M , MausMV, DidianoD, JuneCH, MackensenA, SchneckJP. Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells. Nat. Med.9(5), 619–624 (2003).
  • Maus MV , ThomasAK, LeonardDGet al.: Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4–1BB. Nat. Biotechnol.20(2), 143–148 (2002).
  • Durai M , KruegerC, YeZet al.: In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC). Cancer Immunol. Immunother.58(2), 209–220 (2009).
  • Steenblock ER , FahmyTM. A comprehensive platform for ex vivo T-cell expansion based on biodegradable polymeric artificial antigen-presenting cells. Mol. Ther.16(4), 765–772 (2008).
  • Steenblock ER , FadelT, LabowskyM, PoberJS, FahmyTM. An artificial antigen-presenting cell with paracrine delivery of IL-2 impacts the magnitude and direction of the T cell response. J. Biol. Chem.286(40), 34883–34892 (2011).
  • Engelhard VH , StromingerJL, MescherM, BurakoffS. Induction of secondary cytotoxic T lymphocytes by purified HLA-A and HLA-B antigens reconstituted into phospholipid vesicles. Proc. Natl Acad. Sci. USA75(11), 5688–5691 (1978).
  • Mescher MF . Surface contact requirements for activation of cytotoxic T lymphocytes. J. Immunol.149(7), 2402–2405 (1992).
  • Curtsinger J , DeethsMJ, PeaseP, MescherMF. Artificial cell surface constructs for studying receptor-ligand contributions to lymphocyte activation. J. Immunol. Methods209(1), 47–57 (1997).
  • Turtle CJ , RiddellSR. Artificial antigen-presenting cells for use in adoptive immunotherapy. Cancer J.16(4), 374–381 (2010).
  • Manolova V , FlaceA, BauerM, SchwarzK, SaudanP, BachmannMF. Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol.38(5), 1404–1413 (2008).
  • Gilboa E . The makings of a tumor rejection antigen. Immunity11(3), 263–270 (1999).
  • Jenkins MK , TaylorPS, NortonSD, UrdahlKB. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol.147(8), 2461–2466 (1991).
  • Curtsinger JM , SchmidtCS, MondinoAet al. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J. Immunol. 162(6), 3256–3262 (1999).
  • Grakoui A , BromleySK, SumenCet al. The immunological synapse: a molecular machine controlling T cell activation. Science 285(5425), 221–227 (1999).
  • Lee KH , HoldorfAD, DustinML, ChanAC, AllenPM, ShawAS. T cell receptor signaling precedes immunological synapse formation. Science295(5559), 1539–1542 (2002).
  • Rosenberg SA , PackardBS, AebersoldPMet al. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N. Engl. J. Med. 319(25), 1676–1680 (1988).
  • Dudley ME , WunderlichJR, RobbinsPFet al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298(5594), 850–854 (2002).
  • Kurokawa T , OelkeM, MackensenA. Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells. Int. J. Cancer91(6), 749–756 (2001).
  • Altman JD , MossPA, GoulderPJet al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274(5284), 94–96 (1996).
  • Neudorfer J , SchmidtB, HusterKMet al. Reversible HLA multimers (streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens. J. Immunol. Methods 320 (1–2), 119–131 (2007).
  • Nguyen DN , GreenJJ, ChanJM, LongerR, AndersonDG. Polymeric materials for gene delivery and dna vaccination. Adv. Mater.21(8), 847–867 (2009).
  • Rosenberg SA . Raising the bar: the curative potential of human cancer immunotherapy. Sci. Transl. Med.4(127), 127ps8 (2012).
  • Morgan RA , DudleyME, WunderlichJRet al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314(5796), 126–129 (2006).
  • Giannoni F , BarnettJ, BiKet al. Clustering of T cell ligands on artificial APC membranes influences T cell activation and protein kinase C theta translocation to the T cell plasma membrane. J. Immunol. 174(6), 3204–3211 (2005).
  • Ugel S , ZosoA, De Santo C et al.In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer. Cancer Res.69(24), 9376–9384 (2009).
  • Levine BL , BernsteinWB, ConnorsMet al. Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. J. Immunol. 159(12), 5921–5930 (1997).
  • Maus MV , RileyJL, KwokWW, NepomGT, JuneCH. HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells. Clin. Immunol.106(1), 16–22 (2003).
  • Han H , PengJR, ChenPCet al. A novel system of artificial antigen-presenting cells efficiently stimulates Flu peptide-specific cytotoxic T cells in vitro. Biochem. Biophys. Res. Commun. 411(3), 530–535 (2011).
  • Haveman LM , BieringsM, KleinMRet al. Selection of perforin expressing CD4+ adenovirus-specific T-cells with artificial antigen-presenting cells. Clin. Immunol. 146(3), 228–239 (2013).
  • Schutz C , FleckM, MackensenAet al. Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells. Blood 111(7), 3546–3552 (2008).
  • Schutz C , OelkeM, SchneckJP, MackensenA, FleckM. Killer artificial antigen-presenting cells: the synthetic embodiment of a ‘guided missile‘. Immunotherapy2(4), 539–550 (2010).
  • Webb TJ , BielerJG, SchneckJP, OelkeM. Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen-presenting cells. J. Immunol. Methods346(1–2), 38–44 (2009).
  • Sun W , SubrahmanyamPB, EastJE, WebbTJ. Connecting the dots: artificial antigen-presenting cell-mediated modulation of natural killer T cells. J. Interferon Cytokine Res.32(11), 505–516 (2012).
  • Shiratsuchi T , SchneckJ, KawamuraA, TsujiM. Human CD1 dimeric proteins as indispensable tools for research on CD1-binding lipids and CD1-restricted T cells. J. Immunol. Methods345(1–2), 49–59 (2009).
  • Sauer MG , EricsonME, WeigelBJet al. A novel system for simultaneous in vivo tracking and biological assessment of leukemia cells and ex vivo generated leukemia-reactive cytotoxic T cells. Cancer Res. 64(11), 3914–3921 (2004).
  • O‘Herrin SM , SlanskyJE, TangQet al. Antigen-specific blockade of T cells in vivo using dimeric MHC peptide. J. Immunol. 167(5), 2555–2560 (2001).
  • Pareja E , TobesR, MartinJ, NietoA. The tetramer model: a new view of class II MHC molecules in antigenic presentation to T cells. Tissue Antigens50(5), 421–428 (1997).
  • Deeths MJ , MescherMF. B7-1-dependent co-stimulation results in qualitatively and quantitatively different responses by CD4+ and CD8+ T cells. Eur. J. Immunol.27(3), 598–608 (1997).
  • Deeths MJ , MescherMF. ICAM-1 and B7-1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM-1. Eur. J. Immunol.29(1), 45–53 (1999).
  • Butte MJ , KeirME, PhamduyTB, SharpeAH, FreemanGJ. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity27(1), 111–122 (2007).
  • Ndhlovu ZM , OelkeM, SchneckJP, GriffinDE. Dynamic regulation of functionally distinct virus-specific T cells. Proc. Natl Acad. Sci. USA107(8), 3669–3674 (2010).
  • Fuertes Marraco SA , BaumgaertnerP, LegatA, RuferN, SpeiserDE. A stepwise protocol to coat aAPC beads prevents out-competition of anti-CD3 mAb and consequent experimental artefacts. J. Immunol. Methods385(1–2), 90–95 (2012).
  • Shalaby WS , YehH, WooEet al. Absorbable microparticulate cation exchanger for immunotherapeutic delivery. J. Biomed. Mater. Res. B Appl. Biomater. 69(2), 173–182 (2004).
  • Fahmy TM , SamsteinRM, HarnessCC, Mark Saltzman W. Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting. Biomaterials26(28), 5727–5736 (2005).
  • Pawar AB , KretzschmarI. Fabrication, assembly, and application of patchy particles. Macromol. Rapid Commun.31(2), 150–168 (2010).
  • Walther A , MullerAHE. Janus particles. Soft Matter4(4), 663–668 (2008).
  • Doh J , IrvineDJ. Immunological synapse arrays: patterned protein surfaces that modulate immunological synapse structure formation in T cells. Proc. Natl Acad. Sci. USA103(15), 5700–5705 (2006).
  • Snyder CE , YakeAM, FeickJD, VelegolD. Nanoscale functionalization and site-specific assembly of colloids by particle lithography. Langmuir21(11), 4813–4815 (2005).
  • Cayre O , PaunovVN, VelevOD. Fabrication of dipolar colloid particles by microcontact printing. Chem. Commun. (Camb.)18, 2296–2297 (2003).
  • Cayre O , PaunovVN, VelevOD. Fabrication of asymmetrically coated colloid particles by microcontact printing techniques. J. Mater. Chem.13(10), 2445–2450 (2003).
  • Zhao YP , YeDX, WangGC, LuTM. Novel nano-column and nano-flower arrays by glancing angle deposition. Nano Lett.2(4), 351–354 (2002).
  • Pawar AB , KretzschmarI. Multifunctional patchy particles by glancing angle deposition. Langmuir25(16), 9057–9063 (2009).
  • Zhang G , WangDY, MohwaldH. Patterning microsphere surfaces by templating colloidal crystals. Nano Lett.5(1), 143–146 (2005).
  • Kamalasanan K , JhunjhunwalaS, WuJ, SwansonA, GaoD, LittleSR. Patchy, anisotropic microspheres with soft protein islets. Angew. Chem. Int. Ed. Engl.50(37), 8706–8708 (2011).
  • Serra CA , ChangZQ. Microfluidic-assisted synthesis of polymer particles. Chem. Eng. Technol.31(8), 1099–1115 (2008).
  • Nie ZH , LiW, SeoM, XuSQ, KumachevaE. Janus and ternary particles generated by microfluidic synthesis: design, synthesis, and self-assembly. J. Am. Chem. Soc.128(29), 9408–9412 (2006).
  • Roh KH , MartinDC, LahannJ. Biphasic Janus particles with nanoscale anisotropy. Nat. Mater.4(10), 759–763 (2005).
  • Mossman KD , CampiG, GrovesJT, DustinML. Altered TCR signaling from geometrically repatterned immunological synapses. Science310(5751), 1191–1193 (2005).
  • Pike LJ . Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J. Lipid. Res.47(7), 1597–1598 (2006).
  • Lingwood D , SimonsK. Lipid rafts as a membrane-organizing principle. Science327(5961), 46–50 (2010).
  • Hancock JF . Lipid rafts: contentious only from simplistic standpoints. Nat. Rev. Mol. Cell Biol.7(6), 456–462 (2006).
  • Nicolau DV , BurrageK, PartonRG, HancockJF. Identifying optimal lipid raft characteristics required to promote nanoscale protein–protein interactions on the plasma membrane. Mol. Cell. Biol.26(1), 313–323 (2006).
  • Vogt AB , SpindeldreherS, KropshoferH. Clustering of MHC–peptide complexes prior to their engagement in the immunological synapse: lipid raft and tetraspan microdomains. Immunol. Rev.189, 136–151 (2002).
  • Anderson HA , HiltboldEM, RochePA. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat. Immunol.1(2), 156–162 (2000).
  • Zappasodi R , Di Nicola M, Carlo-Stella C et al. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells. Haematologica93(10), 1523–1534 (2008).
  • Tan S , LiX, GuoY, ZhangZ. Lipid-enveloped hybrid nanoparticles for drug delivery. Nanoscale5(3), 860–872 (2013).
  • Mossman KD , CampiG, GrovesJT, DustinML. Altered TCR signaling from geometrically repatterned immunological synapses. Science310(5751), 1191–1193 (2005).
  • Jin T , PennefatherP, LeePI. Lipobeads: a hydrogel anchored lipid vesicle system. FEBS Lett.397(1), 70–74 (1996).
  • Liu J , JiangX, AshleyC, BrinkerCJ. Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery. J. Am. Chem. Soc.131(22), 7567–7569 (2009).
  • Mornet S , LambertO, DuguetE, BrissonA. The formation of supported lipid bilayers on silica nanoparticles revealed by cryoelectron microscopy. Nano Lett.5(2), 281–285 (2005).
  • Hu CM , ZhangL, AryalS, CheungC, FangRH. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl Acad. Sci. USA108(27), 10980–10985 (2011).
  • Ashley CE , CarnesEC, PhillipsGKet al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat. Mater. 10(5), 389–397 (2011).
  • Porotto M , YiF, MosconaA, LaVanDA. Synthetic protocells interact with viral nanomachinery and inactivate pathogenic human virus. PLoS One6(3), e16874 (2011).
  • Parodi A , QuattrocchiN, van de Ven AL et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat. Nanotechnol.8(1), 61–68 (2013).
  • Fletcher DA , MullinsRD. Cell mechanics and the cytoskeleton. Nature463(7280), 485–492 (2010).
  • Merkel TJ , HerlihyKP, NunesJ, OrgelRM, RollandJP, DeSimoneJM. Scalable, shape-specific, top-down fabrication methods for the synthesis of engineered colloidal particles. Langmuir26(16), 13086–13096 (2010).
  • Glotzer SC , SolomonMJ. Anisotropy of building blocks and their assembly into complex structures. Nat. Mater.6(8), 557–562 (2007).
  • Merkel TJ , JonesSW, HerlihyKPet al. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc. Natl Acad. Sci. USA 108(2), 586–591 (2011).
  • Champion JA , KatareYK, MitragotriS. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J. Control. Release121(1–2), 3–9 (2007).
  • Champion JA , MitragotriS. Role of target geometry in phagocytosis. Proc. Natl Acad. Sci. USA103(13), 4930–4934 (2006).
  • Champion JA , MitragotriS. Shape induced inhibition of phagocytosis of polymer particles. Pharm. Res.26(1), 244–249 (2009).
  • Sharma G , ValentaDT, AltmanYet al. Polymer particle shape independently influences binding and internalization by macrophages. J. Control. Release 147(3), 408–412 (2010).
  • Muro S , GarnachoC, ChampionJAet al. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol. Ther. 16(8), 1450–1458 (2008).
  • Geng Y , DalhaimerP, CaiSet al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2(4), 249–255 (2007).
  • Barua S , YooJW, KolharP, WakankarA, GokarnYR, MitragotriS. Particle shape enhances specificity of antibody-displaying nanoparticles. Proc. Natl Acad. Sci. USA110(9), 3270–3275 (2013).
  • Fadel TR , SteenblockER, SternEet al. Enhanced cellular activation with single walled carbon nanotube bundles presenting antibody stimuli. Nano Lett. 8(7), 2070–2076 (2008).
  • Fadel TR , LookM, StaffierPA, HallerGL, PfefferleLD, FahmyTM. Clustering of stimuli on single-walled carbon nanotube bundles enhances cellular activation. Langmuir26(8), 5645–5654 (2010).
  • Ho CC , KellerA, OdellJA, OttewillRH. Preparation of monodisperse ellipsoidal polystyrene particles. Colloid Polym. Sci.271(5), 469–479 (1993).
  • Champion JA , KatareYK, MitragotriS. Making polymeric micro- and nanoparticles of complex shapes. Proc. Natl Acad. Sci. USA104(29), 11901–11904 (2007).
  • Yoo JW , MitragotriS. Polymer particles that switch shape in response to a stimulus. Proc. Natl Acad. Sci. USA107(25), 11205–11210 (2010).
  • Sunshine JC , PericaK, SchneckJP, GreenJJ. Non-spherical artificial antigen presenting cells for tumor immunotherapy. Presented at: Society For Biomaterials Annual Meeting 2013. Boston, MA, USA, 10–13 April 2013.
  • Rolland JP , MaynorBW, EulissLE, ExnerAE, DenisonGM, DeSimoneJM. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. J. Am. Chem. Soc.127(28), 10096–10100 (2005).
  • Kelly JY , DeSimoneJM. Shape-specific, monodisperse nano-molding of protein particles. J. Am. Chem. Soc.130(16), 5438–5439 (2008).
  • Wang Y , MerkelTJ, ChenK, FromenCA, BettsDE, DeSimoneJM. Generation of a library of particles having controlled sizes and shapes via the mechanical elongation of master templates. Langmuir27(2), 524–528 (2011).
  • Dendukuri D , PregibonDC, CollinsJ, HattonTA, DoylePS. Continuous-flow lithography for high-throughput microparticle synthesis. Nat. Mater.5(5), 365–369 (2006).
  • Yu Y , AiB, MohwaldH, ZhouZW, ZhangG, YangB. Fabrication of binary and ternary hybrid particles based on colloidal lithography. Chem. Mater.24(23), 4549–4555 (2012).
  • Castellino F , HuangAY, Altan-BonnetG, StollS, ScheineckerC, GermainRN. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature440(7086), 890–895 (2006).
  • Banchereau J , SteinmanRM. Dendritic cells and the control of immunity. Nature392(6673), 245–252 (1998).
  • Dustin ML , GrovesJT. Receptor signaling clusters in the immune synapse. Annu. Rev. Biophys.41, 543–556 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.